Cardiff Oncology Inc (CRDF)

EBITDA Margin

-7655.71%

TTM · Period ending:

CRDF logo

CRDF EBITDA Margin

Latest reported-7655.71%
CRDF TTM EBITDA Margin (-19120.90% → -7655.71%)
High-resolution chart · PNG

CRDF ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Cardiff Oncology Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-7,655.7087%
-8,303.8095%
-7,534.0641%
-9,855.2894%
-9,224.359%
-8,218.3673%
-6,582.8947%
-6,178.5196%
-6,081.203%
-6,527.7049%
-8,410.4508%
-8,786.9565%
-9,535.4369%
-9,782.0253%
-9,965.8031%
-9,899.2327%
-9,640.3646%
-9,213.8504%
-7,694.429%
-7,349.0458%
-5,772.9688%
-5,444.0718%
-5,143.6698%
-3,497.0075%
-4,587.6579%
-3,375.0031%
-2,622.6305%
-3,727.6292%
-3,320.3469%
-3,385.6979%
-4,123.394%
-3,005.7932%
-2,883.1899%
-3,403.2775%
-4,138.7943%
-6,615.082%
-8,879.4634%
-9,902.0337%
-9,825.153%
-9,419.8788%
-9,304.813%
-9,914.0307%
-7,946.1153%
-7,605.1055%
-7,131.1922%
-5,108.019%
-4,838.1743%
-4,389.3943%
-4,395.7544%
-6,215.9259%
-5,204.9038%
-5,953.9446%
-3,500.2821%
-2,802.2692%
-3,345.3341%
-1,340.9762%
-2,436.812%
-1,679.5449%
-1,151.1737%
-744.7658%
-1,565.5641%
-1,749.5669%
-2,119.2308%
-12,026.732%
-19,120.905%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.